Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mark Alan Murakami, M.D.

Concepts (142)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lymphoma, Mantle-Cell120232380.720 Why?
Lymphoma, B-Cell120239430.540 Why?
Bone Marrow1202429160.440 Why?
Guanylate Cyclase120232060.200 Why?
CARD Signaling Adaptor Proteins120231650.200 Why?
Xenograft Model Antitumor Assays4201836040.190 Why?
Asparaginase120222400.180 Why?
Tissue and Organ Harvesting120243730.180 Why?
Leukemia, B-Cell12020860.170 Why?
Proto-Oncogene Proteins c-mdm2220183600.150 Why?
Leukocyte Elastase220111130.150 Why?
Lymphoma, Extranodal NK-T-Cell12018520.150 Why?
Micro-Electrical-Mechanical Systems12016280.140 Why?
Bone Marrow Cells1202424110.130 Why?
Bone Marrow Transplantation1202427290.130 Why?
Lymphoma, T-Cell120183080.120 Why?
src-Family Kinases120185380.120 Why?
Tissue Banks120161830.120 Why?
Receptors, Antigen, B-Cell120185450.120 Why?
Neoplasms32017223400.110 Why?
Drug Screening Assays, Antitumor120167150.110 Why?
Cell Transformation, Neoplastic2202028380.110 Why?
Neoplasm, Residual1201810090.100 Why?
Antibodies, Monoclonal, Murine-Derived120156960.100 Why?
Lab-On-A-Chip Devices120164260.100 Why?
Neoplasms, Experimental1201612270.090 Why?
Lymphoma, Follicular120154590.090 Why?
Agranulocytosis12011980.090 Why?
Lymphoma, Non-Hodgkin1201813740.090 Why?
Escherichia coli1202242100.090 Why?
Hematologic Neoplasms1202119260.080 Why?
Hematopoietic Stem Cells1202134050.080 Why?
Granulocytes120115480.080 Why?
Unfolded Protein Response120112390.080 Why?
Leukemia1201615220.070 Why?
Granulocyte Precursor Cells12007490.070 Why?
Tumor Suppressor Protein p531201829450.070 Why?
Signal Transduction32020235970.070 Why?
B-Lymphocytes1202047820.070 Why?
Lymphoma1201618960.070 Why?
Practice Guidelines as Topic1202474230.070 Why?
Peptides1201843310.060 Why?
Neutropenia220118940.060 Why?
Antineoplastic Agents32018136310.060 Why?
Proto-Oncogene Proteins1201845200.060 Why?
Ambulatory Care1201627780.060 Why?
Nuclear Proteins1201857820.050 Why?
Gene Expression Regulation, Neoplastic1201886030.050 Why?
Protein Kinase Inhibitors1201856910.050 Why?
Humans1520247659260.050 Why?
Blood Cell Count120214040.040 Why?
Protein Tyrosine Phosphatase, Non-Receptor Type 6120201210.040 Why?
Proto-Oncogene Proteins c-bcl-6120201900.040 Why?
STAT5 Transcription Factor120202680.040 Why?
Immunotherapy1201547460.040 Why?
Mice72022817820.040 Why?
Imidazolines12018180.040 Why?
Extracellular Signal-Regulated MAP Kinases120206130.040 Why?
Depsipeptides12018950.040 Why?
Neoplasm Recurrence, Local1201593730.030 Why?
Genes, myc120183910.030 Why?
Ikaros Transcription Factor120182300.030 Why?
Emergency Service, Hospital1201678710.030 Why?
Rabbits1202247290.030 Why?
Leukemia, Experimental120162240.030 Why?
Databases as Topic120174720.030 Why?
Chromosome Aberrations1202117750.030 Why?
Janus Kinase 2120185620.030 Why?
Proto-Oncogene Proteins c-myc120209980.030 Why?
Drug Therapy120185040.030 Why?
Antibodies1202224150.030 Why?
Isoquinolines120163500.030 Why?
Enzyme Activation1202035830.030 Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma120162300.030 Why?
Equipment Failure Analysis120168310.030 Why?
Animals720221687350.030 Why?
Genes, p53120167110.030 Why?
Cell Differentiation12011116390.030 Why?
Drug Evaluation, Preclinical1201813310.030 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive120186850.030 Why?
Vincristine1201510370.030 Why?
Cell Line, Tumor22020170600.030 Why?
Remission Induction1201824130.020 Why?
Disease Models, Animal32018182920.020 Why?
Neoplasm Transplantation1201620080.020 Why?
Adenine120189940.020 Why?
Drug Resistance, Neoplasm2201853330.020 Why?
Mice, Inbred NOD1201618370.020 Why?
Random Allocation1201623940.020 Why?
Apoptosis1200795050.020 Why?
Patients120179080.020 Why?
Prednisone1201515660.020 Why?
Cyclophosphamide1201522320.020 Why?
Piperidines1201816640.020 Why?
Mutant Proteins120114860.020 Why?
Doxorubicin1201522260.020 Why?
Equipment Design1201634900.020 Why?
Mutation22015301920.020 Why?
Pyrazoles1201820310.020 Why?
Protein Denaturation120072400.020 Why?
Cell Lineage1201625730.020 Why?
Cell Cycle Proteins1201834310.020 Why?
Myelopoiesis120071350.020 Why?
Proteome1201618960.020 Why?
Protein Binding1201892960.020 Why?
Membrane Proteins1202278470.020 Why?
Pyrimidines1201830490.020 Why?
Treatment Outcome32018651940.020 Why?
Piperazines1201625460.020 Why?
Gene Expression1201875810.020 Why?
Disease-Free Survival1201568380.010 Why?
Molecular Targeted Therapy1201628230.010 Why?
Dose-Response Relationship, Drug12016107270.010 Why?
Medical Oncology1201623390.010 Why?
Neoplasm Proteins1201635920.010 Why?
Internet1201631060.010 Why?
Critical Care1201627130.010 Why?
Protein Folding120078680.010 Why?
Pilot Projects1201687240.010 Why?
Mice, Knockout12018144500.010 Why?
Length of Stay1201664860.010 Why?
Cells, Cultured12016189620.010 Why?
Cell Proliferation12016104260.010 Why?
Female520203961410.010 Why?
Research Design1201662040.010 Why?
Gene Expression Profiling1201695250.010 Why?
Randomized Controlled Trials as Topic12016103800.010 Why?
Mice, Transgenic1201195410.010 Why?
Phenotype12016167140.010 Why?
Male420163638150.010 Why?
Hospitalization12016108100.010 Why?
Prognosis12015298900.010 Why?
Aged220161711630.010 Why?
Mice, Inbred C57BL12011223270.010 Why?
Middle Aged220162230160.010 Why?
Adult220162230880.010 Why?
Aged, 80 and over12016594960.010 Why?
Young Adult12016598570.010 Why?
Pregnancy12011302300.000 Why?
Risk Factors12015748500.000 Why?
Adolescent12016888110.000 Why?
Retrospective Studies12015815370.000 Why?
Murakami's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (142)
Explore
_
Co-Authors (64)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.